Add to Cart View Cart/Checkout More Products

Volume 10, 2006 CD

Six back issues of The International Journal of Pharmaceutical Compounding from 2006 on one convenient CD.
Only $95 per CD.
(Multiple Theme or Library CD orders priced at: 2 to 5 = $85; 6 to 9 = $75; 10 or more = $65 each.)

  • Permanant storage and easy retrieval of IJPC articles, formulations, SOP's and more.
  • Print IJPC articles in color for your marketing needs.

The back issues are stored as a high-resolution, full-color Adobe Portable Document Format (.pdf) file, complete with an electronic Table of Contents.

They may be searched by keyword and printed by the page. Software to read the PDF file is freely available from the Adobe Reader page.

Issues
Volume/IssueDateTitle
Vol. 10 No. 1 January/February 2006 Sports Medicine
Vol. 10 No. 2 March/April 2006 Hospice/Palliative Care
Vol. 10 No. 3 May/June 2006 Hormone Replacement Therapy
Vol. 10 No. 4 July/August 2006 Sterile Preparations
Vol. 10 No. 5 September/October 2006 Dermatology
Vol. 10 No. 6 November/December 2006 Veterinary Compounding

Articles
Volume/IssuePageTitle
Vol. 10 No. 1 2 PreScription: A Decade of IJPC
Vol. 10 No. 1 5 CompoundingToday.com: Literature, Book Reviews, & More
Vol. 10 No. 1 6 Compounding Pharmacy: The Past Decade
Vol. 10 No. 1 9 Levorphanol, Methadone, and the Management of Intractable Chronic Pain: An Interview with Kerry Schmidt, BA, MBA; Jack P. McNulty, MD, FACP; and George B. Muller, RPh
Vol. 10 No. 1 14 Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery
Vol. 10 No. 1 20 Pharmaceutical Legislation: An Historical Perspective
Vol. 10 No. 1 32 Pharmacy Compounding Urban Legends
Vol. 10 No. 1 36 Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations
Vol. 10 No. 1 41 Quality Control Analytical Methods: Common Concerns about Out-of-Specification Results
Vol. 10 No. 1 44 Acacia and Mineral Oil Emulsion NF
Vol. 10 No. 1 46 How'd They Do That?
Vol. 10 No. 1 50 Profile: The McGuff Companies, Part 2: Corporate Cooperation Supports Growth and Ensures Financial Success
Vol. 10 No. 1 56 Standard Operating Procedure: Shipping of Prescriptions
Vol. 10 No. 1 58 Calculations
Vol. 10 No. 1 59 Chlorambucil 2-mg/mL Oral Liquid
Vol. 10 No. 1 60 Dantrolene Sodium 5-mg/mL Oral Liquid
Vol. 10 No. 1 61 Domperidone 1-mg/mL Oral Liquid
Vol. 10 No. 1 62 Efavirenz 20-mg/mL Oral Liquid, Anhydrous
Vol. 10 No. 1 63 Medium-Chain Triglycerides Oral Vehicle, Anhydrous
Vol. 10 No. 1 64 Mercaptopurine 50-mg/mL Oral Liquid
Vol. 10 No. 1 65 Misoprostol 1-mg Suppository
Vol. 10 No. 1 66 Naratriptan Hydrochloride 0.5-mg/mL Oral Liquid
Vol. 10 No. 1 67 Propylthiouracil 5-mg/mL Oral Liquid
Vol. 10 No. 1 68 Thioguanine 40-mg/mL Oral Liquid
Vol. 10 No. 1 69 Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management
Vol. 10 No. 1 74 Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds
Vol. 10 No. 1 79 Scientific and Professional Reviewers for 2005
Vol. 10 No. 1 80 PostScription: Stopping Drug Reps at the Door
Vol. 10 No. 2 82 PreScription: The Squeaky Wheel Gets the Grease!
Vol. 10 No. 2 82 Erratum: Allen LV Jr. Lidocaine hydrochloride 2%, misoprostol 0.0024%, and phenytoin 2% topical wound powder. IJPC 2004; 8(4): 298
Vol. 10 No. 2 86 Compounding Pharmacy: The Past Decade, Part 2 -- Equipment Advances
Vol. 10 No. 2 89 Hospice from a Compounding Pharmacist's Perspective
Vol. 10 No. 2 95 ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient
Vol. 10 No. 2 100 The Story of Hospice
Vol. 10 No. 2 103 The Dying Process
Vol. 10 No. 2 107 Probiotic Therapy, Part 1: Beneficial Bacteria Improve Health, Save Lives
Vol. 10 No. 2 113 Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist
Vol. 10 No. 2 122 Basics of Compounding for Dentistry, Part 1: Effective Approaches and Formulations
Vol. 10 No. 2 128 Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 1
Vol. 10 No. 2 135 Standard Operating Procedure: Labconco Basic 47 Laboratory Hood
Vol. 10 No. 2 136 Calculations
Vol. 10 No. 2 137 Amlodipine 1-mg/mL Oral Liquid
Vol. 10 No. 2 138 Chloroquine Phosphate 15-mg/mL Oral Liquid
Vol. 10 No. 2 139 Cimetidine 60-mg/mL Oral Liquid, Alcohol Free
Vol. 10 No. 2 140 Disopyramide Phosphate 1-mg/mL Oral Liquid
Vol. 10 No. 2 141 Mycophenolate Mofetil 50-mg/mL Oral Liquid
Vol. 10 No. 2 142 Norfloxacin 20-mg/mL Oral Liquid
Vol. 10 No. 2 143 Saquinavir 60-mg/mL Oral Liquid
Vol. 10 No. 2 144 Sotalol Hydrochloride 5-mg/mL Oral Liquid
Vol. 10 No. 2 145 Terbinafine Hydrochloride 25-mg/mL Oral Liquid
Vol. 10 No. 2 146 Trazodone Hydrochloride 10-mg/mL Oral Liquid
Vol. 10 No. 2 147 Initial Selection of Antiemetics in End-of-Life Care: A Retrospective Analysis
Vol. 10 No. 2 154 Chemical Stability of Diclofenac Sodium Injection
Vol. 10 No. 2 156 Extended Stability of Oxytocin in Common Infusion Solutions
Vol. 10 No. 2 159 PostScription: Treatment of Chronic Pain with Methadone or Levorphanol
Vol. 10 No. 3 162 PreScription: Standards, Legal Standards, and Accreditation
Vol. 10 No. 3 165 Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate
Vol. 10 No. 3 172 Case Report: Hydroxyprogesterone Caproate Injection for Prevention of Preterm Labor
Vol. 10 No. 3 175 The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States
Vol. 10 No. 3 187 Patient Satisfaction with Pharmacist Intervention and Consultation in Hormone Replacement Therapy: An Update
Vol. 10 No. 3 195 Probiotic Therapy, Part 2: Clinical Perspectives
Vol. 10 No. 3 201 Quick Tips for Managing Market Directors
Vol. 10 No. 3 202 Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns?
Vol. 10 No. 3 205 Basics of Compounding for Dentistry, Part 2: Tooth Whitening
Vol. 10 No. 3 208 Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2
Vol. 10 No. 3 213 Wise Buys: Choosing the Right Software for a Compounding Pharmacy
Vol. 10 No. 3 218 Standard Operating Procedure: Sterility Test for Ophthalmic Solutions
Vol. 10 No. 3 219 Calculations
Vol. 10 No. 3 220 Carvedilol 1.25-mg/mL Oral Suspension
Vol. 10 No. 3 221 Enalapril Maleate 1-mg/mL Oral Suspension
Vol. 10 No. 3 222 Granisetron 0.05-mg/mL Oral Suspension
Vol. 10 No. 3 223 Lamotrigine 1-mg/mL Oral Suspension
Vol. 10 No. 3 224 Mesna 20-mg/mL Syrup
Vol. 10 No. 3 225 Mexiletine Hydrochloride 10-mg/mL Oral Suspension
Vol. 10 No. 3 226 Pyrimethamine 2-mg/mL Oral Suspension
Vol. 10 No. 3 227 Quinapril 1-mg/mL Oral Liquid
Vol. 10 No. 3 228 Theophylline 5-mg/mL Oral Liquid, Alcohol-Free
Vol. 10 No. 3 229 Triamcinolone Acetonide 0.1% Mouthwash Solution
Vol. 10 No. 3 230 Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration
Vol. 10 No. 3 234 Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration
Vol. 10 No. 3 237 Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together
Vol. 10 No. 3 240 PostScription: Tempted to Bill Compounds to Third-Party Cards? Don't Put Your Reimbursement or Contract at Risk!
Vol. 10 No. 4 242 PreScription: 6-Year or 7-Year Program?
Vol. 10 No. 4 245 Introduction to Hospital Compounding
Vol. 10 No. 4 253 Training and Competency Considerations for Pharmacies Providing Compounded Sterile Preparations
Vol. 10 No. 4 263 Putting the Science Back into the "Art and Science" of Compounding
Vol. 10 No. 4 270 Compounded Treatment Options for Cystitis and Other Bladder Problems
Vol. 10 No. 4 277 Teaching Lab Renovation: University of Texas at Austin College of Pharmacy Combines Sterile and Nonsterile Compounding Lab Spaces
Vol. 10 No. 4 281 Quality Control Analytical Methods: A Guide to Quality Control Testing for the Compounding Pharmacist
Vol. 10 No. 4 287 What are You Willing to Do?
Vol. 10 No. 4 288 Hospice Symptom Relief Kit: An Update
Vol. 10 No. 4 291 Innovations in Compounding: Integrated Barcode System Verifies Chemical Identity, Weight
Vol. 10 No. 4 293 Aseptic Compounding in New Zealand and the Use of Still Air Boxes
Vol. 10 No. 4 296 Standard Operating Procedure: Testing of Water Supply: Barnstead D4751 High Purity Water System
Vol. 10 No. 4 298 Calculations
Vol. 10 No. 4 299 Adderall 1-mg/mL Oral Liquid
Vol. 10 No. 4 300 Dapsone 2-mg/mL Oral Liquid
Vol. 10 No. 4 301 Itraconazole 40-mg/mL Oral Liquid
Vol. 10 No. 4 302 Lisinopril 1-mg/mL Oral Liquid
Vol. 10 No. 4 303 Nifedipine 4-mg/mL Oral Liquid
Vol. 10 No. 4 304 Propranolol Hydrochloride 1-mg/mL Oral Liquid
Vol. 10 No. 4 305 Rifabutin 20-mg/mL Oral Liquid
Vol. 10 No. 4 306 Sildenafil Citrate 2.5-mg/mL Oral Liquid
Vol. 10 No. 4 307 Tramadol Hydrochloride 5-mg/mL Oral Liquid
Vol. 10 No. 4 308 Tramadol Hydrochloride 7.5-mg/mL and Acetaminophen 65-mg/mL Oral Liquid
Vol. 10 No. 4 309 Physical Assessments of Lipid Injectable Emulsions via Microscopy: A Comparison to Methods Proposed in the United States Pharmacopeia Chapter <729>
Vol. 10 No. 4 316 Stability of Memantine in an Extemporaneously Prepared Oral Liquid
Vol. 10 No. 4 318 Chemical Stability of Pyridoxine Hydrochloride 100-mg/mL Injection, Preservative Free
Vol. 10 No. 4 320 PostScription: Patients or Clients?
Vol. 10 No. 5 322 PreScription: Certification and Accreditation
Vol. 10 No. 5 324 Topical Cidofovir for Treatment of Resistant Viral Infections
Vol. 10 No. 5 331 Mesotherapy: Cosmetic Applications
Vol. 10 No. 5 336 Dermatological Effects from Years in the Sun: Compounding Opportunities
Vol. 10 No. 5 344 Migraine: A General Approach to Prevention and Treatment
Vol. 10 No. 5 351 Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches
Vol. 10 No. 5 353 University of North Carolina at Chapel Hill School of Pharmacy Pharmaceutical Care Laboratories: Compounding Laboratory Curriculum and Renovation
Vol. 10 No. 5 361 Education, Training, and Evaluation of Hospital Compounding Personnel
Vol. 10 No. 5 369 MEDLINE: A Valuable Research Tool for the Compounding Pharmacist
Vol. 10 No. 5 372 Quality-Control Analytical Methods: Sterility Failure Investigations
Vol. 10 No. 5 377 Basics of Compounding for Hazardous Drugs, Part 1: An Introduction
Vol. 10 No. 5 380 Calculations
Vol. 10 No. 5 381 Standard Operating Procedure: Procedures in the Event of Nonconformance of Bulk Chemicals or Compounded Preparations
Vol. 10 No. 5 382 Famotidine 8-mg/mL Oral Liquid
Vol. 10 No. 5 383 Fluconazole 1-mg/mL Liquid for Nasogastric Tube Administration
Vol. 10 No. 5 384 Hydroxyurea 100 mg/mL
Vol. 10 No. 5 385 Indinavir 10-mg/mL Oral Liquid
Vol. 10 No. 5 386 Lisinopril 1-mg/mL, Sodium Citrate, and Citric Acid Oral Liquid
Vol. 10 No. 5 387 Midazolam Hydrochloride 1-mg/mL Oral Liquid
Vol. 10 No. 5 388 Nitrazepam 1-mg/mL Oral Liquid
Vol. 10 No. 5 389 Omeprazole 2-mg/mL Oral Liquid
Vol. 10 No. 5 390 Oral Rehydration Salts (World Health Organization/United Nations Children's Fund)
Vol. 10 No. 5 391 Pantoprazole Sodium 2-mg/mL Oral Liquid
Vol. 10 No. 5 392 In Vitro Transdermal Diffusion of Zileuton from a Topical Gel
Vol. 10 No. 5 396 Temozolomide Stability in Extemporaneously Compounded Oral Suspensions
Vol. 10 No. 5 400 PostScription: Moving Pharmacy Compounding into the 21st Century and Beyond
Vol. 10 No. 6 402 PreScription: International Journal of Pharmaceutical Compounding is Expanding
Vol. 10 No. 6 405 Application of Sildenafil for Pulmonary Hypertension in Canines and Foals
Vol. 10 No. 6 411 Compounding for Feline Herpetic Keratitis
Vol. 10 No. 6 417 Compounding for Veterinary Medicine
Vol. 10 No. 6 418 Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety
Vol. 10 No. 6 421 Taurine for the Treatment of Canine Dilated Cardiomyopathy
Vol. 10 No. 6 426 Case Report: Treatment of Canine Colitis in a Dachshund with a Compounded Oral Tri-Mix (Green Lizard)
Vol. 10 No. 6 428 BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle
Vol. 10 No. 6 434 Ronidazole in the Treatment of Trichomonad Infections in Cats
Vol. 10 No. 6 436 Equipment, Supplies, and Facilities Required for Hospital Compounding
Vol. 10 No. 6 442 Quality Control Analytical Methods: Continuous Quality Improvement
Vol. 10 No. 6 446 Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Vol. 10 No. 6 449 Calculations: Compounding for Large and Small Animals
Vol. 10 No. 6 450 Standard Operating Procedure: Inventory--Veterinary Drugs and Supplies
Vol. 10 No. 6 452 Amiloride Hydrochloride 1-mg/mL Oral Liquid
Vol. 10 No. 6 453 Chloral Hydrate 50-mg/mL Oral Liquid
Vol. 10 No. 6 454 Cyclophosphamide 2-mg/mL Oral Liquid
Vol. 10 No. 6 455 Disulfiram 25-mg/mL Oral Liquid
Vol. 10 No. 6 456 Gabapentin 100-mg/mL Oral Liquid
Vol. 10 No. 6 457 Hydralazine Hydrochloride 1-mg/mL or 10-mg/mL Oral Liquid
Vol. 10 No. 6 458 Indomethacin 2-mg/mL Oral Liquid
Vol. 10 No. 6 459 Naltrexone 1-mg/mL Oral Liquid
Vol. 10 No. 6 460 Terbutaline Sulfate 1-mg/mL Oral Liquid
Vol. 10 No. 6 461 Valacyclovir 50-mg/mL Oral Liquid
Vol. 10 No. 6 462 Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists
Vol. 10 No. 6 469 Validation Study of the Unguator, an Apparatus for Compounding Dermatological Preparations
Vol. 10 No. 6 479 PostScription: Challenges Facing an Analytical Laboratory